Clinical TrialID 437
A "Window Trial" on Curcumin for Invasive Breast Cancer Primary Tumors
NCT03980509
Breast Cancer
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Herb: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 437
- Evidence Id
- 437
- Core Evidence Id
- 437
- Source Clinical Trial Id
- 423
- Herb2 Clinical Trial Id
- HBCT000423
- Nct Id
- NCT03980509
- Title
- A "Window Trial" on Curcumin for Invasive Breast Cancer Primary Tumors
- Status
- Active_Not_Recruiting
- Phase
- Phase 1
- Study Result
- No
- Study Condition
- Breast Cancer
- Study Type
- Interventional
- Study Design
- Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
- Intervention
- DRUG: Curcumin
- Intervention Allocation
- Intervention Model
- Single_Group
- Intervention Mask
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Adult, Older_Adult
- Enrollment
- 22
- Outcome Measure
- Change in tumor proliferation rate, Change in tumor proliferation rate will be based on apoptosis (DNA fragmentation) and cell proliferation (Ki67) assays in biopsies pre and post treatment with curcumin, Up to 56 days
- Sponsor Collaborator
- Medical University of South Carolina
- Funded By
- OTHER
- Location
- Medical University of South Carolina, Charleston, South Carolina, 29425, United States
- Other Id
- 103089
- Start Date
- 2020-01-29
- Primary Completion Date
- 2024-09-30
- Completion Date
- 2024-12-31
- First Posted
- 2019-06-10
- Results First Posted
- Last Update Posted
- 2024-09-19
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT03980509
- Title Cn
- Title En
- A "Window Trial" on Curcumin for Invasive Breast Cancer Primary Tumors
- Bilingual Status
- semi_complete